Shanghai Hile Bio-Technology Co., Ltd. (SHA:603718)
China · Delayed Price · Currency is CNY 3.250
+0.030 (0.93%)
Sep 2, 2026, 3:00 PM CST
SHA:603718 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 149.74 | 214.31 | 358.5 | 140.74 | 156.55 | 153.04 |
Trading Asset Securities | 195.62 | 210.84 | 158.58 | 212.48 | 236.15 | 385.59 |
Cash & Short-Term Investments | 345.36 | 425.14 | 517.08 | 353.22 | 392.71 | 538.63 |
Cash Growth | -33.05% | -17.78% | 46.39% | -10.06% | -27.09% | 3.44% |
Accounts Receivable | 126.68 | 101.98 | 108.97 | 84.95 | 97.41 | 89.95 |
Other Receivables | 12.17 | 3.14 | 2.92 | 4.91 | 7.67 | 31.43 |
Receivables | 138.85 | 105.12 | 111.89 | 89.86 | 105.08 | 121.37 |
Inventory | 104.85 | 59.46 | 55.01 | 102.82 | 144.89 | 142.62 |
Other Current Assets | 11.76 | 6.12 | 7.79 | 16.65 | 22.36 | 172.82 |
Total Current Assets | 600.82 | 595.84 | 691.77 | 562.55 | 665.03 | 975.44 |
Property, Plant & Equipment | 142.58 | 52.89 | 60.6 | 164.6 | 219.45 | 275.9 |
Long-Term Investments | 0.34 | - | - | 639.09 | 315.32 | 224.7 |
Goodwill | 563.58 | 381.82 | 1,006 | 225.33 | 224.14 | 224.14 |
Other Intangible Assets | 47.21 | 50.7 | 55.58 | 38.1 | 73.56 | 100.23 |
Long-Term Deferred Tax Assets | - | 0.01 | 0.74 | 18.6 | 12.45 | 8.46 |
Long-Term Deferred Charges | 24.35 | 22.23 | 5.92 | 9.16 | 3.34 | 5.32 |
Other Long-Term Assets | 0.68 | 21.62 | 6.52 | 0.3 | 0.96 | 29.91 |
Total Assets | 1,380 | 1,125 | 1,827 | 1,658 | 1,514 | 1,844 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 26.5 | 7.32 | 6.79 | 28.56 | 42.29 | 39.43 |
Accrued Expenses | 12.13 | 17.47 | 25.13 | 9.52 | 23.08 | 32.83 |
Short-Term Debt | 23 | 3.23 | - | 270.19 | 133.39 | 473.04 |
Current Portion of Long-Term Debt | 15.34 | - | - | - | - | - |
Current Portion of Leases | - | 3.18 | 3.66 | 0.83 | 9.86 | 2.01 |
Current Income Taxes Payable | 11.03 | 4.28 | 8.76 | 4.99 | 24.73 | 7.81 |
Current Unearned Revenue | 20.62 | 7.86 | 9.81 | 21.61 | 15.46 | 32.63 |
Other Current Liabilities | 118.45 | 68.19 | 46.09 | 81.34 | 71.94 | 82.22 |
Total Current Liabilities | 227.07 | 111.54 | 100.25 | 417.04 | 320.75 | 669.96 |
Long-Term Debt | 45.6 | - | - | - | - | - |
Long-Term Leases | 21.36 | 10.4 | 13.94 | - | 14.87 | 2.62 |
Long-Term Unearned Revenue | - | - | - | 64.45 | 66.26 | 182.19 |
Long-Term Deferred Tax Liabilities | 105.71 | 107.2 | 9.46 | 1.47 | 1.37 | 2.12 |
Total Liabilities | 408 | 229.14 | 123.65 | 482.96 | 403.25 | 856.9 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 651.9 | 655.66 | 657.9 | 657.9 | 644 | 644 |
Additional Paid-In Capital | 215.11 | 229.32 | 281.86 | 229.69 | 139.86 | 131.57 |
Retained Earnings | 39.15 | 28.29 | 663.1 | 398.41 | 372.05 | 250.44 |
Treasury Stock | -13.27 | -31.23 | -42.38 | -66.44 | - | - |
Comprehensive Income & Other | - | - | - | -2.57 | -15.57 | -20.41 |
Total Common Equity | 892.9 | 882.04 | 1,560 | 1,217 | 1,140 | 1,006 |
Minority Interest | 78.67 | 13.93 | 142.72 | -42.19 | -29.33 | -18.41 |
Shareholders' Equity | 971.57 | 895.97 | 1,703 | 1,175 | 1,111 | 987.19 |
Total Liabilities & Equity | 1,380 | 1,125 | 1,827 | 1,658 | 1,514 | 1,844 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 105.3 | 16.81 | 17.6 | 271.02 | 158.12 | 477.66 |
Net Cash (Debt) | 240.06 | 408.34 | 499.49 | 82.2 | 234.59 | 60.97 |
Net Cash Growth | -52.01% | -18.25% | 507.66% | -64.96% | 284.77% | 13.27% |
Net Cash Per Share | 0.37 | 0.63 | 0.76 | 0.13 | 0.37 | 0.09 |
Filing Date Shares Outstanding | 667.96 | 651.9 | 655.66 | 657.9 | 644 | 644 |
Total Common Shares Outstanding | 667.96 | 655.66 | 657.9 | 657.9 | 644 | 644 |
Working Capital | 373.75 | 484.3 | 591.53 | 145.51 | 344.28 | 305.48 |
Book Value Per Share | 1.34 | 1.35 | 2.37 | 1.85 | 1.77 | 1.56 |
Tangible Book Value | 282.11 | 449.51 | 499.19 | 953.55 | 842.63 | 681.23 |
Tangible Book Value Per Share | 0.42 | 0.69 | 0.76 | 1.45 | 1.31 | 1.06 |
Buildings | - | 23.4 | 23.4 | 168.06 | 166.12 | 289.13 |
Machinery | - | 57.33 | 42.64 | 157.38 | 179.48 | 231.62 |
Construction In Progress | - | - | 12.72 | 0.75 | 5.24 | 2.94 |